15-11　ⓔ文献

  1. Ito T, Igarashi H, et al: Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol, 2015; 50: 58–64.

  2. Scarpa A, Chang DK, et al: Whole–genome landscape of pancreatic neuroendocrine tumours. Nature, 2017; 543: 65–71.

  3. Caplin ME, Pavel M, et al: Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med, 2014; 371: 224–233.

  4. Yao JC, Shah MH, et al: RAD001 in advanced neuroendocrine tumors, Third Trial (RADIANT–3) Study Group. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med, 2011; 364: 514–523.

  5. Raymond E, Dahan L, et al: Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med, 2011; 364: 501–513.